当前位置: X-MOL 学术J. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
The Journal of Infectious Diseases ( IF 6.4 ) Pub Date : 2020-07-09 , DOI: 10.1093/infdis/jiaa245
Tomas G Neilan 1 , Kim-Lien Nguyen 2 , Vlad G Zaha 3 , Kara W Chew 4 , Leavitt Morrison 5 , Ntobeko A B Ntusi 6 , Mabel Toribio 7 , Magid Awadalla 1 , Zsofia D Drobni 1 , Michael D Nelson 8 , Tricia H Burdo 9 , Marije Van Schalkwyk 10 , Paul E Sax 11 , Daniel J Skiest 12 , Karen Tashima 13 , Raphael J Landovitz 14 , Eric Daar 15 , Alysse G Wurcel 16 , Gregory K Robbins 17 , Robert K Bolan 18 , Kathleen V Fitch 7 , Judith S Currier 4 , Gerald S Bloomfield 19 , Patrice Desvigne-Nickens 20 , Pamela S Douglas 21 , Udo Hoffmann 1 , Steven K Grinspoon 7 , Heather Ribaudo 5 , Rodney Dawson 22 , Matthew Bidwell Goetz 23 , Mamta K Jain 24 , Alberta Warner 2 , Lidia S Szczepaniak 25 , Markella V Zanni 7
Affiliation  

People with human immunodeficiency virus (PWH) face increased risks for heart failure and adverse heart failure outcomes. Myocardial steatosis predisposes to diastolic dysfunction, a heart failure precursor. We aimed to characterize myocardial steatosis and associated potential risk factors among a subset of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) participants.

中文翻译:

参加 REPRIEVE 试验的抗逆转录病毒疗法治疗的人类免疫缺陷病毒患者的心肌脂肪变性。

人类免疫缺陷病毒 (PWH) 患者面临更高的心力衰竭风险和心力衰竭不良后果。心肌脂肪变性易导致舒张功能障碍,这是心力衰竭的先兆。我们的目的是在预防 HIV 血管事件随机试验 (REPRIEVE) 参与者的子集中描述心肌脂肪变性和相关潜在危险因素的特征。
更新日期:2020-07-09
down
wechat
bug